Chemist billionaire in $297m Sigma selldown bolsters ASX turnover
MELBOURNE: Damien Gance, a director of Sigma Health and Chemist Warehouse co-founder Sam ... read more
Epiminder targets 2025 IPO in mayor boost to prospects
MELBOURNE: Cochlear-backed Epiminder has its sights set on an Australian initial public offering ... read more
Mayne flags FY earnings jump despite weak quarter performance
MELBOURNE: ASX-listed pharma takeover target Mayne expects full year underlying earnings to range ... read more
